BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$626M |
| 2 |
Invesco QQQ Trust
QQQ
|
$518M |
| 3 |
Cadence Design Systems
CDNS
|
$193M |
| 4 |
Goldman Sachs
GS
|
$177M |
| 5 |
BP
BP
|
$166M |
Top Sells
| 1 |
Alibaba
BABA
|
$1.54B |
| 2 |
DuPont de Nemours
DD
|
$719M |
| 3 |
Visa
V
|
$502M |
| 4 |
Amazon
AMZN
|
$475M |
| 5 |
NVIDIA
NVDA
|
$375M |
Sector Composition
| 1 | Technology | 22.75% |
| 2 | Healthcare | 11.51% |
| 3 | Consumer Discretionary | 10.03% |
| 4 | Financials | 8.82% |
| 5 | Communication Services | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
UnitedHealth
UNH
$280B
| $274M | 0.35% |
544,004
-13,755
| -2% | -$6.94M |
|
27
PepsiCo
PEP
$206B
| $267M | 0.34% |
1,577,251
+147,377
| +10% | +$25M |
|
28
Micron Technology
MU
$133B
| $252M | 0.32% |
3,701,686
+1,039,772
| +39% | +$70.7M |
|
29
Eli Lilly
LLY
$659B
| $250M | 0.32% |
465,990
+148,044
| +47% | +$79.5M |
|
30
Thermo Fisher Scientific
TMO
$184B
| $244M | 0.31% |
482,237
-291,439
| -38% | -$148M |
|
31
iShares US Real Estate ETF
IYR
$3.69B
| $243M | 0.31% |
3,112,592
+1,164,075
| +60% | +$91M |
|
32
Walt Disney
DIS
$213B
| $242M | 0.31% |
2,989,836
+1,232,020
| +70% | +$99.9M |
|
|
33
Goldman Sachs
GS
$221B
| $233M | 0.3% |
720,746
+546,773
| +314% | +$177M |
|
34
Berkshire Hathaway Class B
BRK.B
$1.08T
| $230M | 0.3% |
657,014
-980
| -0.1% | -$343K |
|
35
Verizon
VZ
$185B
| $230M | 0.3% |
7,083,658
+2,992,419
| +73% | +$97M |
|
36
Industrial Select Sector SPDR Fund
XLI
$23.1B
| $227M | 0.29% |
2,239,497
-2,343,182
| -51% | -$238M |
|
37
Chevron
CVX
$326B
| $222M | 0.29% |
1,317,439
+594,144
| +82% | +$100M |
|
|
38
DuPont de Nemours
DD
$31.7B
| $219M | 0.28% |
2,931,522
-9,639,958
| -77% | -$719M |
|
39
Merck
MRK
$214B
| $218M | 0.28% |
2,117,624
+726,956
| +52% | +$74.8M |
|
40
SPDR S&P Biotech ETF
XBI
$5.25B
| $213M | 0.27% |
2,916,437
+201,302
| +7% | +$14.7M |
|
41
Procter & Gamble
PG
$370B
| $211M | 0.27% |
1,449,229
+869,666
| +150% | +$127M |
|
42
Accenture
ACN
$160B
| $211M | 0.27% |
685,795
+63,297
| +10% | +$19.4M |
|
43
Comcast
CMCSA
$126B
| $208M | 0.27% |
4,695,384
-1,906,236
| -29% | -$84.5M |
|
44
Qualcomm
QCOM
$171B
| $202M | 0.26% |
1,821,103
+360,385
| +25% | +$40M |
|
45
Applied Materials
AMAT
$126B
| $199M | 0.26% |
1,437,737
+396,431
| +38% | +$54.9M |
|
46
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.7B
| $198M | 0.25% |
2,688,608
+462,326
| +21% | +$34.1M |
|
47
Costco
COST
$416B
| $192M | 0.25% |
340,554
-138,631
| -29% | -$78.3M |
|
48
Danaher
DHR
$146B
| $191M | 0.25% |
768,456
+122,786
| +19% | +$30.5M |
|
49
O'Reilly Automotive
ORLY
$87.6B
| $189M | 0.24% |
208,235
-47,250
| -18% | -$42.9M |
|
|
50
BP
BP
$90.8B
| $189M | 0.24% |
4,872,626
+4,285,199
| +729% | +$166M |
|